| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052269583 |
| P356 | DOI | 10.1038/NATURE12595 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nature12595 |
| P698 | PubMed publication ID | 24121438 |
| P50 | author | Arthur Christopoulos | Q18977850 |
| Meritxell Canals | Q46120848 | ||
| James R Valcourt | Q56938571 | ||
| Celine Valant | Q56938593 | ||
| Ron Ofer Dror | Q59678272 | ||
| Raphael Rahmani | Q63509783 | ||
| J. Robert Lane | Q63923479 | ||
| Jonathan B Baell | Q87721461 | ||
| Patrick M. Sexton | Q39936838 | ||
| David W. Borhani | Q42390809 | ||
| P2093 | author name string | David E Shaw | |
| Albert C Pan | |||
| Daniel H Arlow | |||
| Hillary F Green | |||
| P2860 | cites work | Electrostatics of nanosystems: application to microtubules and the ribosome | Q24555224 |
| Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders | Q24605472 | ||
| Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3 | Q46529162 | ||
| Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors. | Q51797215 | ||
| 221. The constitution of aspidospermine. Part III. Reactivity at the nitrogen atoms, and biogenetic considerations | Q55968231 | ||
| Millisecond-scale molecular dynamics simulations on Anton | Q56019493 | ||
| Reversible multiple time scale molecular dynamics | Q56157167 | ||
| Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
| N+/Si Replacement as a Tool for Probing the Pharmacophore of Allosteric Modulators of Muscarinic M2Receptors: Synthesis, Allosteric Potency, and Positive Cooperativity of Silicon-Based W84 Derivatives | Q58856361 | ||
| Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis | Q72478593 | ||
| Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors | Q73201612 | ||
| Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity | Q83206375 | ||
| The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors | Q24605967 | ||
| Structure and function of an irreversible agonist-β(2) adrenoceptor complex | Q24620291 | ||
| Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist | Q24628686 | ||
| CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields | Q24632987 | ||
| Crystal structure of the β2 adrenergic receptor-Gs protein complex | Q24635327 | ||
| Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations | Q24645752 | ||
| Flexible ligand docking to multiple receptor conformations: a practical alternative | Q24650066 | ||
| Crystal structure of metarhodopsin II | Q27666911 | ||
| Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions | Q27670746 | ||
| Structure and dynamics of the M3 muscarinic acetylcholine receptor | Q27677433 | ||
| All-atom empirical potential for molecular modeling and dynamics studies of proteins | Q27860468 | ||
| VMD: visual molecular dynamics | Q27860554 | ||
| Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations | Q29547631 | ||
| Atomic-level characterization of the structural dynamics of proteins | Q29616380 | ||
| Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types | Q29616710 | ||
| A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations | Q30040038 | ||
| Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation | Q30489795 | ||
| Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations. | Q30501558 | ||
| Pathway and mechanism of drug binding to G-protein-coupled receptors. | Q30503489 | ||
| Allosteric Modulation of Muscarinic Acetylcholine Receptors | Q33664703 | ||
| Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3Adenosine Receptor | Q34190610 | ||
| The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling | Q34297570 | ||
| Gaussian split Ewald: A fast Ewald mesh method for molecular simulation | Q34399119 | ||
| Protonation states of membrane-embedded carboxylic acid groups in rhodopsin and metarhodopsin II: a Fourier-transform infrared spectroscopy study of site-directed mutants. | Q36639738 | ||
| Allosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands | Q37140580 | ||
| Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. | Q37773544 | ||
| Structure-based drug screening for G-protein-coupled receptors | Q38002626 | ||
| How does a drug molecule find its target binding site? | Q39280041 | ||
| Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. | Q42277559 | ||
| How robust are protein folding simulations with respect to force field parameterization? | Q42853031 | ||
| Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors | Q44219305 | ||
| Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-o | Q44483391 | ||
| Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors | Q44483424 | ||
| Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors | Q44719359 | ||
| P433 | issue | 7475 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 295-299 | |
| P577 | publication date | 2013-10-13 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs | |
| P478 | volume | 503 |
| Q39213631 | A Hidden Active Site in the Potential Drug Target Mycobacterium tuberculosis dUTPase Is Accessible through Small Amplitude Protein Conformational Changes |
| Q100467881 | A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion |
| Q38610941 | A cross docking pipeline for improving pose prediction and virtual screening performance. |
| Q47935295 | A kinetic view of GPCR allostery and biased agonism |
| Q90468092 | A mechanism for the activation of the mechanosensitive Piezo1 channel by the small molecule Yoda1 |
| Q50616685 | A pose prediction approach based on ligand 3D shape similarity. |
| Q89531733 | A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity |
| Q33699049 | Accelerated molecular dynamics simulations of ligand binding to a muscarinic G-protein-coupled receptor |
| Q37281443 | Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor |
| Q55518791 | AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses. |
| Q86445952 | Allosteric Modulation of Substrate Binding within a Tetracationic Molecular Receptor |
| Q35333859 | Allosteric effects of sodium ion binding on activation of the m3 muscarinic g-protein-coupled receptor |
| Q36988985 | Allosteric modulation in monomers and oligomers of a G protein-coupled receptor |
| Q92881989 | Allosteric modulation of β-cell M3 muscarinic acetylcholine receptors greatly improves glucose homeostasis in lean and obese mice |
| Q39248479 | Allostery at opioid receptors: modulation with small molecule ligands. |
| Q36907408 | An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology |
| Q64114989 | Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators |
| Q47384821 | Are there physicochemical differences between allosteric and competitive ligands? |
| Q38918905 | Binding Kinetics in Drug Discovery |
| Q28468325 | Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors |
| Q55092101 | Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor. |
| Q41315904 | Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling |
| Q28541837 | Chemical, target, and bioactive properties of allosteric modulation |
| Q28607245 | Cheminformatics Research at the Unilever Centre for Molecular Science Informatics Cambridge |
| Q83224304 | Common activation mechanism of class A GPCRs |
| Q35967903 | Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors |
| Q38605343 | Computational Membrane Biophysics: From Ion Channels Interactions with Drugs to Cellular Function |
| Q36927686 | Computational approaches to detect allosteric pathways in transmembrane molecular machines |
| Q36683075 | Configurational space discretization and free energy calculation in complex molecular systems |
| Q92134678 | Conformational Complexity and Dynamics in a Muscarinic Receptor Revealed by NMR Spectroscopy |
| Q92133857 | Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs |
| Q89834875 | Current Advances in Allosteric Modulation of Muscarinic Receptors |
| Q62495036 | Current Strategies and Applications for Precision Drug Design |
| Q91754192 | Determinants of Orexin Receptor Binding and Activation-A Molecular Dynamics Study |
| Q33922348 | Differences in allosteric communication pipelines in the inactive and active states of a GPCR. |
| Q33742774 | Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor |
| Q30489011 | Docking Screens for Novel Ligands Conferring New Biology |
| Q64984096 | Dual binding mode of "bitter sugars" to their human bitter taste receptor target. |
| Q47374327 | Dynamic Docking: A Paradigm Shift in Computational Drug Discovery |
| Q27313967 | Dynamic Motion and Communication in the Streptococcal C1 Phage Lysin, PlyC |
| Q29248852 | Entropy Transfer between Residue Pairs and Allostery in Proteins: Quantifying Allosteric Communication in Ubiquitin |
| Q33638068 | Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias |
| Q90439302 | Exploring Biological Networks in 3D, Stereoscopic 3D, and Immersive 3D with iCAVE |
| Q53076714 | Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design. |
| Q35671393 | From G Protein-coupled Receptor Structure Resolution to Rational Drug Design. |
| Q39184034 | Future De Novo Drug Design |
| Q33639685 | G protein-coupled receptors in cardiac biology: old and new receptors |
| Q39419666 | G-Protein coupled receptors: answers from simulations |
| Q38300811 | G-protein coupled receptor solubilization and purification for biophysical analysis and functional studies, in the total absence of detergent. |
| Q38848557 | G-protein coupled receptors: advances in simulation and drug discovery |
| Q55481649 | Gaussian Accelerated Molecular Dynamics: Theory, Implementation, and Applications. |
| Q27301372 | Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation |
| Q37379758 | Graded activation and free energy landscapes of a muscarinic G-protein-coupled receptor |
| Q35549133 | Homologous ligands accommodated by discrete conformations of a buried cavity |
| Q35972120 | Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator |
| Q34461713 | Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor |
| Q38610791 | Improvements to the APBS biomolecular solvation software suite |
| Q52665081 | In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease. |
| Q50675544 | In silico study of the structurally similar ORL1 receptor agonist and antagonist pairs reveal possible mechanism of receptor activation. |
| Q99239350 | In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation |
| Q34497517 | Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5). |
| Q39165104 | Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures. |
| Q89510669 | Integrated Computational Approaches and Tools forAllosteric Drug Discovery |
| Q42555102 | Intrinsic flexibility of NLRP pyrin domains is a key factor in their conformational dynamics, fold stability, and dimerization |
| Q47132843 | Investigating Small-Molecule Ligand Binding to G Protein-Coupled Receptors with Biased or Unbiased Molecular Dynamics Simulations |
| Q56989238 | Investigating allosteric effects on the functional dynamics of β2-adrenergic ternary complexes with enhanced-sampling simulations |
| Q27344829 | Investigation of allosteric modulation mechanism of metabotropic glutamate receptor 1 by molecular dynamics simulations, free energy and weak interaction analysis |
| Q38973739 | Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target |
| Q41829504 | Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor |
| Q53839652 | Mechanism of the G-protein mimetic nanobody binding to a muscarinic G-protein-coupled receptor. |
| Q93087286 | Mechanism of β2AR regulation by an intracellular positive allosteric modulator |
| Q34580443 | Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor. |
| Q35533294 | Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis |
| Q39319839 | Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities |
| Q48020118 | Molecular Dynamics Methodologies for Probing Cannabinoid Ligand/Receptor Interaction |
| Q91588369 | Molecular Dynamics Simulation for All |
| Q37608542 | Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor. |
| Q26772040 | Molecular dynamics simulations of biological membranes and membrane proteins using enhanced conformational sampling algorithms |
| Q39449058 | Multiscale design of coarse-grained elastic network-based potentials for the μ opioid receptor |
| Q37369524 | Multiscale implementation of infinite-swap replica exchange molecular dynamics |
| Q26999429 | Muscarinic acetylcholine receptor X-ray structures: potential implications for drug development |
| Q38218059 | Muscarinic acetylcholine receptors: novel opportunities for drug development |
| Q38933295 | New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova |
| Q91165293 | Nontargeted Parallel Cascade Selection Molecular Dynamics Based on a Nonredundant Selection Rule for Initial Structures Enhances Conformational Sampling of Proteins |
| Q28081112 | Novel Allosteric Modulators of G Protein-coupled Receptors |
| Q47348671 | Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs |
| Q34399823 | Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders |
| Q47301262 | Pharmacological Evidence for a Putative Conserved Allosteric Site on Opioid Receptors. |
| Q52737158 | Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors. |
| Q58048721 | Prediction of hydration free energies for the SAMPL4 diverse set of compounds using molecular dynamics simulations with the OPLS-AA force field |
| Q88734577 | Probing the binding site of novel selective positive allosteric modulators at the M1 muscarinic acetylcholine receptor |
| Q37108546 | Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors |
| Q37232244 | Protein Allostery and Conformational Dynamics. |
| Q35611767 | Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism. |
| Q90391732 | Quantum Mechanical and Molecular Mechanics Modeling of Membrane-Embedded Rhodopsins |
| Q39152860 | Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors |
| Q92373510 | Recent Advances in Coarse-Grained Models for Biomolecules and Their Applications |
| Q93017246 | Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery |
| Q57175255 | Recent Trends and Applications of Molecular Modeling in GPCR⁻Ligand Recognition and Structure-Based Drug Design |
| Q26747130 | Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations |
| Q55689469 | Role of conformational dynamics in the evolution of novel enzyme function. |
| Q49422353 | Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53. |
| Q36229483 | Self-Organizing Global Gene Expression Regulated through Criticality: Mechanism of the Cell-Fate Change |
| Q26785992 | Small Molecule Targeting of Protein-Protein Interactions through Allosteric Modulation of Dynamics |
| Q59340309 | Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A Receptor |
| Q90332751 | Structural Features and Ligand Selectivity for 10 Intermediates in the Activation Process of β2-Adrenergic Receptor |
| Q40660620 | Structural Insight into Specificity of Interactions between Nonconventional Three-finger Weak Toxin from Naja kaouthia (WTX) and Muscarinic Acetylcholine Receptors |
| Q35652476 | Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor |
| Q59082343 | Structural insights into G-protein-coupled receptor allostery |
| Q97535797 | Structure and selectivity engineering of the M1 muscarinic receptor toxin complex |
| Q57175420 | Structure-Activity Relationships of Pan-Gα Coupled Muscarinic Acetylcholine Receptor Positive Allosteric Modulators |
| Q49914169 | Structure-based discovery of selective positive allosteric modulators of antagonists for the M2 muscarinic acetylcholine receptor. |
| Q91898809 | Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes |
| Q48226745 | Synthesis of novel and functionally selective non-competitive muscarinic antagonists as chemical probes. |
| Q91749643 | Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development |
| Q41052388 | Temperature-sensitive gating of TRPV1 channel as probed by atomistic simulations of its trans- and juxtamembrane domains. |
| Q34489039 | The Dynamic Process of Drug-GPCR Binding at Either Orthosteric or Allosteric Sites Evaluated by Metadynamics |
| Q35590418 | The OPEP protein model: from single molecules, amyloid formation, crowding and hydrodynamics to DNA/RNA systems |
| Q28554455 | The Open Form Inducer Approach for Structure-Based Drug Design |
| Q93085802 | The Opioid Crisis and the Future of Addiction and Pain Therapeutics |
| Q28551894 | The Quantum Nature of Drug-Receptor Interactions: Deuteration Changes Binding Affinities for Histamine Receptor Ligands |
| Q26862004 | The ensemble nature of allostery |
| Q27334167 | The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor |
| Q38237899 | The receptor concept in 3D: from hypothesis and metaphor to GPCR-ligand structures |
| Q59287278 | The size matters? A computational tool to design bivalent ligands |
| Q64068088 | Understanding Ligand Binding to G-Protein Coupled Receptors Using Multiscale Simulations |
| Q38868297 | Update on melatonin receptors: IUPHAR Review 20. |
| Q92409897 | Utilization of Biased G Protein-Coupled ReceptorSignaling towards Development of Safer andPersonalized Therapeutics |
| Q38983852 | Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs |
| Q31096633 | Water Determines the Structure and Dynamics of Proteins |
| Q34785448 | What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands? |
Search more.